查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654271

止血与组织密封剂市场规模、份额、趋势分析报告：按产品、材料、应用、最终用途、地区和细分市场、预测，2025-2030 年

Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product, By Material, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 210 Pages | 商品交期: 2-10个工作天内

价格

止血和组织密封剂市场的成长和趋势

根据 Grand View Research, Inc. 的一份新报告，全球止血和组织密封剂市场预计到 2030 年将达到 144.8 亿美元。

预计 2025 年至 2030 年间，市场复合年增长率将达到 9.0%。这种增长归因于人们对微创手术的日益偏好，因为这种手术创伤较小，且需要的恢復时间较短。此外，医疗技术的进步和需要手术的慢性病发病率的上升也促进了这一增长。此外，止血和组织密封产品的技术创新也在推动市场的发展。这些产品的开发是为了满足各个医疗专业领域的需求，并在各种医疗保健环境中提供有效、高效的手术解决方案。

在预计预测期内，微创技术的快速成长和对更快患者康復的需求将推动市场成长。根据美国美国1.5 亿人患有至少一种需要手术治疗、有时甚至导致死亡的慢性疾病。预计手术数量的增加最终将推动市场成长。

根据美国疾病管制与预防中心（CDC）的估计，超过 48% 的美国人口患有慢性疾病，这是市场成长的主要驱动力之一。此外，由于手术数量的增加、老年人口的增加和技术的进步，预计止血和组织密封剂市场对产品的需求将增加。一些市场参与企业专注于产品发布、併购和产品核可，以维持其市场地位。例如，2023年11月，强生公司医疗技术部门Ethicon推出止血封贴片Ethizia，并获得欧洲上市核准，成为其欧洲医疗产品的重要补充。

止血和组织密封剂市场报告重点

  • 2024年，局部止血剂领域占据最大的市场占有率。这是因为它越来越多地与传统治疗方法结合使用，并且具有成本效益、止血剂吸收快速简便、组织反应性最小和非抗原性等特征。
  • 2024 年，北美地区占据了最大的市场占有率，这得益于该地区完善的医疗保健基础设施以及心血管疾病、糖尿病和癌症患病率的不断上升。
  • 市场参与企业正在采取多项策略倡议来扩大其产品覆盖范围并提高不同地区的可用性。
  • 主要市场参与企业包括百特、强生、贝朗、史密斯和侄子以及碧迪公司。
  • 材料科学和生物工程的发展正在推动具有更好性能特征的新型和改良黏合剂和密封剂的开发。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章止血与组织密封剂市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 止血与组织密封剂市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章止血与组织密封剂市场：产品、估计与趋势分析

  • 细分仪表板
  • 止血剂和组织密封剂市场：2023 年和 2030 年产品变化分析和市场占有率
  • 局部止血剂
  • 合成止血剂

第 5 章止血剂和组织密封剂市场：按材料分類的估计和趋势分析

  • 细分仪表板
  • 止血与组织密封剂市场：材料变化分析与市场占有率，2023 年与 2030 年
  • 明胶基局部止血剂
  • 胶原蛋白局部外用止血剂
  • 基于ORC的局部止血剂
  • 多醣类局部止血剂

第 6 章止血与组织密封剂市场：按应用分類的估计和趋势分析

  • 细分仪表板
  • 止血和组织密封剂市场：应用趋势分析和市场占有率，2023 年和 2030 年
  • 一般外科
  • 神经外科
  • 血管外科
  • 心血管外科
  • 其他的

7. 止血与组织密封剂市场：最终用途、估计与趋势分析

  • 细分仪表板
  • 止血和组织密封剂市场：最终用途变化分析和市场占有率，2024 年和 2030 年
  • 医院
  • 门诊手术中心
  • 其他的

8. 止血和组织密封剂市场：区域、估计和趋势分析

  • 区域展望
  • 止血剂和组织密封剂市场：区域差异分析和市场占有率，2024 年和 2030 年
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Johnson & Johnson
    • CryoLife Inc
    • Advance Medical Solution（AMS）Group Plc
    • Cohera Medical Inc
    • Integra Life Sciences Corporation
    • Pfizer
    • BD
    • Cohesion Technologies Inc
    • HyperBranch Medical Technology
    • Biomet Inc
    • Medtronic
    • B Braun Medical Inc
    • Smith &Nephew
Product Code: 978-1-68038-597-7

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is anticipated to reach USD 14.48 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.0% from 2025 to 2030. This growth can be attributed to the increasing preference towards minimally invasive surgical procedures, which are less invasive and require less recovery time. Additionally, advancements in healthcare technology and the rising prevalence of chronic diseases that require surgery are contributing to this growth. The market is also benefiting from ongoing innovation in hemostatic and tissue sealing products, which are being developed to meet the needs of a wide range of medical specialties and to provide effective and efficient surgical solutions in various healthcare settings.

The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times. Such a rise in the number of surgeries is eventually anticipated to foster market growth.

The Centers for Disease Control and Prevention (CDC) estimates that over 48% of the entire American population is expected to suffer from chronic conditions, which is one of the key drivers of this growth. The hemostasis & tissue sealing agents market is also expected to witness an increase in product demand supported by rising surgery volumes, growth in the geriatric population, and technological advancements. Several market participants are focusing on product launches, merger & acquisitions & product approval to sustain their market position. For instance, In November 2023, Johnson & Johnson's MedTech division, Ethicon, introduced Ethizia, a hemostatic sealing patch, obtaining European approval for its launch, marking a significant addition to their medical offerings in Europe.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

  • In 2024, the topical hemostat segment accounted for the largest market share due to its rising use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
  • The North American region held the largest share of the market in 2024 due to well-established healthcare infrastructure, and the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.
  • Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas.
  • Some of the major market players are Baxter, Johnson & Johnson, B. Braun, Smith & Nephew, Becton, Dickinson, and Company
  • Advancements in material science and bioengineering have led to the development of new and improved adhesives and sealants with better performance characteristics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Rising preference towards minimally invasive surgical procedures
      • 3.2.1.3. Growing geriatric population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product recall & failure
  • 3.3. Hemostasis & Tissue Sealing Agents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hemostasis & Tissue Sealing Agents Market: Product Movement Analysis & Market Share, 2023 & 2030
  • 4.3. Topical Hemostats
    • 4.3.1. Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Active
        • 4.3.1.1.1. Active market estimates and forecast 2018 to 2030 (USD Million)
      • 4.3.1.2. Mechanical
        • 4.3.1.2.1. Mechanical market estimates and forecast 2018 to 2030 (USD Million)
      • 4.3.1.3. Flowable
        • 4.3.1.3.1. Flowable market estimates and forecast 2018 to 2030 (USD Million)
      • 4.3.1.4. Adhesive & Tissue Sealant
        • 4.3.1.4.1. Adhesive & Tissue Sealant market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4. Synthetic Hemostats
    • 4.4.1. Synthetic Hemostasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Natural
        • 4.4.1.1.1. Natural market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.1.2. Adhesion Barrier
        • 4.4.1.2.1. Adhesion Barrier market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hemostasis & Tissue Sealing Agents Market: Material Movement Analysis & Market Share, 2023 & 2030
  • 5.3. Gelatin-based Topical Hemostats
    • 5.3.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Collagen-based Topical Hemostats
    • 5.4.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. ORC-based Topical Hemostats
    • 5.5.1. ORC-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Polysaccharide-based Topical Hemostats
    • 5.6.1. Polysaccharide-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hemostasis & Tissue Sealing Agents Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Hemostasis & Tissue Sealing Agents Market: Application Movement Analysis & Market Share, 2023 & 2030
  • 6.3. General Surgery
    • 6.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Neurosurgery
    • 6.4.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Vascular Surgery
    • 6.5.1. Vascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiovascular Surgery
    • 6.6.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hemostasis & Tissue Sealing Agents Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Hemostasis & Tissue Sealing Agents Market: End-use Movement Analysis & Market Share, 2024 & 2030
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Hemostasis & Tissue Sealing Agents Market: Regional Movement Analysis & Market Share, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. UK Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Germany Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. France Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Italy Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Spain Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Denmark Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Sweden Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Reimbursement scenario
      • 8.4.9.5. Norway Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. Japan Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. China Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. India Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. South Korea Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Australia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Thailand Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Brazil Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Mexico Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. Argentina Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. South Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Saudi Arabia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. UAE Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Reimbursement scenario
      • 8.7.5.5. Kuwait Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Johnson & Johnson
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. CryoLife Inc
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Advance Medical Solution (AMS) Group Plc
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Cohera Medical Inc
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Integra Life Sciences Corporation
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Pfizer
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. BD
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Cohesion Technologies Inc
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. HyperBranch Medical Technology
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Biomet Inc
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Medtronic
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. B Braun Medical Inc
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Smith & Nephew
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 5 Global hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America hemostasis and tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 10 North America hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 14 U.S. hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 18 Canada hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 23 Europe hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 UK hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 27 UK hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 31 Germany hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 34 France hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 35 France hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 36 France hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 39 Italy hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 43 Spain hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Norway hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 46 Norway hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 47 Norway hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 48 Norway hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 51 Sweden hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Denmark hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 54 Denmark hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 55 Denmark hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 56 Denmark hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Japan hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 63 Japan hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 64 Japan hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 65 Japan hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 67 China hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 68 China hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 69 China hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 71 India hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 72 India hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 73 India hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Australia hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 75 Australia hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 76 Australia hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 77 Australia hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Korea hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Korea hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 80 South Korea hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Thailand hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 84 Thailand hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 89 Latin America hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Brazil hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 93 Brazil hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 97 Mexico hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 101 Argentina hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 110 South Africa hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 118 UAE hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 122 Kuwait hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait hemostats market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Hemostats market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Hemostasis and tissue sealing agents market, product outlook key takeaways (USD Million)
  • Fig. 12 Hemostasis and tissue sealing agents market: product movement analysis 2024 & 2030 (USD Million)
  • Fig. 13 Topical hemostat market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Adhesive & tissue sealant market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Hemostasis and tissue sealing agents market, material outlook key takeaways (USD Million)
  • Fig. 16 Hemostasis and tissue sealing agents market: material movement analysis 2024 & 2030 (USD Million)
  • Fig. 17 Gelatin-based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Collagen based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 ORC- based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Polysaccharide-based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Hemostasis and tissue sealing agents market, application outlook key takeaways (USD Million)
  • Fig. 22 Hemostasis and tissue sealing agents market: application movement analysis 2024 & 2030 (USD Million)
  • Fig. 23 General surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Neurosurgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Vascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Cardiovascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Hemostasis and tissue sealing agents market, end-use outlook key takeaways (USD Million)
  • Fig. 29 Hemostasis and tissue sealing agents market: end-use movement analysis 2024 & 2030 (USD Million)
  • Fig. 30 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Hemostasis and tissue sealing agents market : Regional key takeaways (USD Million)
  • Fig. 34 Hemostasis and tissue sealing agents market: Regional outlook, 2024 & 2030 (USD Million)
  • Fig. 35 North America hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 List of key emerging company's/technology disruptors/innovators